Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INTUITIVE SURGICAL, INC.

(ISRG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Intuitive Surgical : Evercore ISI Adjusts Intuitive Surgical's Price Target to $980 from $825, Keeps In Line Rating

07/21/2021 | 09:28am EDT


© MT Newswires 2021
All news about INTUITIVE SURGICAL, INC.
09/13INSIDER SELL : Intuitive Surgical
MT
09/10INSIDER SELL : Intuitive Surgical
MT
09/10INTUITIVE SURGICAL : Downside Attributed by Traders Reacting to Guidance Cut at ..
MT
09/01Intuitive Surgical On Track for Record High Close -- Data Talk
DJ
08/31Intuitive Appoints New General Manager in South Korea
GL
08/30INTUITIVE SURGICAL : Prior Art Showing An Invention To Be "At Least Possible" Fo..
AQ
08/26INTUITIVE SURGICAL : SVB Leerink Adjusts Intuitive Surgical's Price Target to $1..
MT
08/05INTUITIVE SURGICAL INC : Other Events (form 8-K)
AQ
08/05Intuitive Board of Directors Approves a Three-For-One Stock Split
GL
07/22INTUITIVE SURGICAL : Deutsche Bank Adjusts Price Target for Intuitive Surgical t..
MT
More news
Analyst Recommendations on INTUITIVE SURGICAL, INC.
More recommendations
Financials (USD)
Sales 2021 5 643 M - -
Net income 2021 1 657 M - -
Net cash 2021 3 029 M - -
P/E ratio 2021 83,4x
Yield 2021 -
Capitalization 123 B 123 B -
EV / Sales 2021 21,3x
EV / Sales 2022 18,6x
Nbr of Employees 8 081
Free-Float 99,0%
Chart INTUITIVE SURGICAL, INC.
Duration : Period :
Intuitive Surgical, Inc. Technical Analysis Chart | ISRG | US46120E6023 | MarketScreener
Technical analysis trends INTUITIVE SURGICAL, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 1 037,27 $
Average target price 990,75 $
Spread / Average Target -4,48%
EPS Revisions
Managers and Directors
Gary S. Guthart President, Chief Executive Officer & Director
Marshall L. Mohr Chief Financial Officer & Executive Vice President
Calvin Darling Senior Director-Finance & Investor Relations
Craig H. Barratt Chairman
Myriam J. Curet Chief Medical Officer & Executive Vice President
Sector and Competitors